The Efficacy of High-Intensity Focused Ultrasound Therapy on Adenomyosis
HIFU
1 other identifier
observational
20
1 country
1
Brief Summary
To assess the efficacy of High-Intensity Focused Ultrasound on adenomyosis
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Sep 2026
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 3, 2026
CompletedFirst Posted
Study publicly available on registry
September 8, 2026
CompletedStudy Start
First participant enrolled
September 16, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2028
September 8, 2026
September 1, 2026
2.3 years
September 3, 2026
September 3, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Dysmenorrhea
The changes of VAS scores of dysmenorrhea
6 months
Secondary Outcomes (6)
Menorrhagia
6 months
Overactive bladder symptoms
6 months
Female sexual function
6 months
Bowel incontinence
6 months
Overall condition of dysmenorrhea
6 months
- +1 more secondary outcomes
Study Arms (1)
Adenomyosis
adenomyosis of the uterus
Interventions
Eligibility Criteria
Patients with symptomatic uterine adenomyosis:
You may qualify if:
- The patient must be at least 18 years old.
- Adenomyosis: There must be several dark areas on at least one side of the uterine wall; the uterine wall must be thickened; in addition, the thickened uterine wall must have a nonhomogeneous structure; and clinically, there must be dysmenorrhea or menorrhagia.
You may not qualify if:
- The patient currently has an acute lower urinary tract infection or intestinal inflammation.
- The patient has previously undergone bladder or urethral surgery.
- The patient has a history of urinary tract stones or tumors.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Obstetrics and Gynecology, Far Eastern Memorial Hospital
Banqiao District, New Taipei, 22050, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief of Department of Obstetrics and Gynecology
Study Record Dates
First Submitted
September 3, 2026
First Posted
September 8, 2026
Study Start
September 16, 2026
Primary Completion (Estimated)
December 31, 2028
Study Completion (Estimated)
December 31, 2028
Last Updated
September 8, 2026
Record last verified: 2026-09